-
New Players Take the Field: How Private Employer Healthcare Could Mean More Focus on People
Feb 25, 2020, 12:05 PM by Michael CroftFull storyBio-IT World Contributed Commentary | Depending on which side of the gurney you find yourself, the U.S. healthcare system can be simultaneously viewed as either a modern-day gold rush or an impossible financial burden. In large part, this is because humans have been displaced by business objectives as the focal point of healthcare. If you’re seeking some sign of restored equilibrium between massive healthcare corporations (59 of the S&P 500 companies are healthcare-related) and the individuals they are meant to serve, there’s an inkling of real change, growing out of an unlikely corner… other massive corporations.
-
Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
Feb 25, 2020, 10:09 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Banks intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roches PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumorsFull story -
The Pistoia Alliance’s UDM Project Reaches Major Milestone
Feb 25, 2020, 09:15 AM by Michael CroftBOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)Full story -
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.
Feb 25, 2020, 08:36 AM by Michael CroftPRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, IncFull story -
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
Feb 25, 2020, 04:50 AM by Michael CroftCAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapiesFull story -
Streck to present new tube at TRI-CON
Feb 24, 2020, 10:20 AM by Michael CroftLA VISTA, NE - Feb 24, 2020 - Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San FranciscoFull story -
Rare Disease Patient Platform Raremark Partners With TriNetX
Feb 24, 2020, 09:32 AM by Michael CroftCAMBRIDGE, MA - Feb 24, 2020 - TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its communityFull story -
Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis
Feb 24, 2020, 05:19 AM by Michael CroftGLASGOW, SCOTLAND - Feb 24, 2020 - Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETER(TM) wearable biosensor deviceFull story -
Aalto Bio Reagents Launches First Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Protein
Feb 24, 2020, 05:13 AM by Michael CroftDUBLIN, IRELAND - Feb 24, 2020 - Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6404) for diagnostic test manufacturers, vaccine developers and researchers globallyFull story -
Creative Diagnostics Introduces Innovative Zebrafish Antibodies
Feb 24, 2020, 03:31 AM by Michael CroftSHIRLEY, NY - Feb 25, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches a large range of antibodies against key immune molecules in zebrafish to enhance the research within the fish scientific community as well as mammalian immune disorders researchesFull story -
MGI Announces April Availability Of Sequencers, Reagents In US
Feb 21, 2020, 18:05 PM by Michael CroftBio-IT World MGI, part of global genomics leader BGI Group, announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s own innovative CoolMPS sequencing chemistry, starting in April of this year.Full story -
Creative Proteomics Released BrdU Cell Proliferation Assay to Be Behind Researchers
Feb 20, 2020, 21:48 PM by Michael CroftSHIRLEY, NY - Feb 21, 2020 - February 21, 2020, since its establishment in 2004, Creative Proteomics has served nearly 2 million researchers from different areas, including clinical, academia and industryFull story -
The Value Of Imaging Data As The Missing Essential Component Of Real World Data
Feb 20, 2020, 10:30 AM by Michael CroftBio-IT World Contributed Commentary | Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).Full story -
Absolute Antibody Partners with the Technical University of Denmark to Offer Antibodies against Animal Venom Toxins
Feb 20, 2020, 09:40 AM by Michael CroftREDCAR, UK - Feb 20, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venomsFull story -
Follow the Money: Big Investments In CRISPR, Cell Therapies, Health Data Management
Feb 19, 2020, 15:20 PM by Michael CroftBio-IT World | Some big investments are driving CRISPR-based therapeutics, cell therapies, sepsis diagnostics and more this year. Unspecified investments by pharma are further propelling Seqster’s health data management platform.Full story -
From Ending Addiction to Preventive Genomics, Bio-IT World 2020 Keynoters Share Data-Driven Approaches
Feb 19, 2020, 13:30 PM by Michael CroftNEEDHAM, MA, UNITED STATES - Feb 19, 2020 - Bio-IT World 2020, the premier conference and expo uniting life science, data science, informatics and IT leaders, today announced its Plenary Keynote sessionsFull story -
Creative Biolabs Provides Anti-EGFR Therapeutic Antibody---Nimotuzumab for Research Use
Feb 18, 2020, 23:09 PM by Michael CroftSHIRLEY, NY, USE - Feb 19, 2020 - February 19, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody field, announced that the nimotuzumab, a kind of anti-EGFR therapeutic antibody, is now available for research and clinical useFull story -
Greenphire and Roche Team to Address Critical Clinical Trial Patient Convenience Issues at 11th Annual SCOPE Summit
Feb 18, 2020, 09:03 AM by Michael CroftORLANDO, FL, UNITED STATES - Feb 18, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced that it has teamed with top industry sponsor, Roche (SIX: RO, ROG;OTCQX: RHHBY), to address the top hurdles patients face when participating in clinical trialsFull story -
Signant Health invests for growth with the opening of its new Philadelphia-area office
Feb 18, 2020, 08:57 AM by Michael CroftPHILADELPHIA - Feb 18, 2020 - Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office facility in Blue Bell, PennsylvaniaFull story -
Optibrium appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development
Feb 18, 2020, 08:50 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Feb 18, 2020 - Optibrium, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business DevelopmentFull story